-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of the State Food and Drug Administration showed that Zhejiang Lepu Pharmaceutical’s acarbose tablets were submitted for approval in the imitation of 4 types of acarbose tablets.
According to data, Acarbose tablets are an alpha-glycosidase inhibitor developed by Bayer, which is mainly used in combination with diet control to treat type 2 diabetes and reduce the postprandial blood sugar of people with impaired glucose tolerance.
Overall sales of acarbose tablets
Source: Minet database
According to data from Meinenet, in 2019, the total sales of acarbose tablets in China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) terminals and Chinese urban physical pharmacies terminals totaled nearly 100 100 million yuan.
Source: MED2.
In terms of consistency evaluation, acarbose tablets have been reviewed by 7 pharmaceutical companies.
Source: official website of the State Food and Drug Administration, Mi Nei.